FDAnews
www.fdanews.com/articles/197861-oxford-to-resume-global-trial-of-hydroxychloroquine-to-prevent-covid-19
hydroxychloroquine pill bottle

Oxford to Resume Global Trial of Hydroxychloroquine to Prevent COVID-19

July 1, 2020

The University of Oxford is resuming recruitment for its global clinical trial of hydroxychloroquine and chloroquine for possible prevention of COVID-19 infections.  

The large-scale trial, which aims to enroll 40,000 healthcare workers, was paused after a now-retracted study found the antimalarial drugs had no benefit as a treatment for COVID-19 patients.  The findings of the retracted study were based on suspect data so UK regulators have told Oxford they can resume the study of the drug for the prevention of COVID-19.

The UK arm of the trial will resume recruitment this week, and new sites are being established in Thailand and Southeast Asia, Africa and South America.

View today's stories